Business Description

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. We are currently focused on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity.

The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology that enables minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is epilepsy, future applications in Parkinson’s disease, Essential tremors, and Dystonia are additional conditions we plan to target.

NeuroOne technologies will be presented to a well-defined market which we believe will be eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration. Learn more >>

IR Contacts

Investor Relations
Dave Rosa
President and CEO
contact@neurooneinc.com

U.S. Legal Council
Honigman Miller Schwartz and Cohn
660 Woodward Avenue
Detroit, MI 48226

Auditor
BDO USA
800 Nicollet Mall Suite 600
Minneapolis, MN 55405

Transfer Agent
Action Stock Transfer
(801) 274-1088
action@actionstocktransfer.com

Industry Classifications

Sector
Surgical and Medical Instruments and Apparatus

SIC
3841

Frequently Asked Questions

Can I buy stock directly from NeuroOne?
No, you will need to contact a licensed stock broker or use an online trading account

How can I buy stock in NeuroOne?
Through a licensed stock broker or by using an online trading account

How do I get my purchased shares?
Contact Action Stock Transfer by telephone at (801) 274-1088 or by email at action@actionstocktransfer.com

What is NeurOne’s CUSIP number?
64130M100

Who can I contact for general information about NeuroOne?
Email us at contact@neurooneinc.com

Where is NeuroOne located?
10006 Liatris Lane, Eden Prairie, MN 55347

When was NeuroOne incorporated?
We were originally incorporated in the state of Nevada on August 20, 2009 as Original Source Entertainment, Inc. We changed our name to NeuroOne Medical Technologies Corporation and reincorporated in Delaware before we entered into an agreement and plan of merger on July 20, 2017 to acquire NeuroOne, Inc., which was incorporated under the laws of the State of Delaware on October 7, 2016. The NeuroOne, Inc. predecessor entity, NeuroOne LLC, was formed on December 13, 2013 and operated as a limited liability company until it was merged with and into NeuroOne, Inc.

When is NeuroOne’s fiscal year end?
December 31st

Who are NeuroOne’s independent auditors?
BDO USA LLP

Who is NeuroOne’s outside legal counsel?
Honigman Miller Schwartz and Cohn LLP